Hence, reduced BVR-A phosphorylation along with the decreased interaction with ERK2 observed in an AD hippocampus [117] lend support to the hypothesis that BVR-A may contribute to the observed ERK1/2 dysfunction in AD [122,123,124,125]. Here, MAPK3 is linked to Alzheimer disease.